World’s First Automated Detection of Lymph Node Metastasis of Colon CancerApplication of OSNA Method Extended from Breast Cancer to Colon Cancer
Sysmex to Launch the PROWELL Opti Health Guidance Optimization Service, a SaaS Service to Help Manage Employee Health-A New Procedure for Supporting Health Maintenance Among Corporate Employees-
Sysmex Wins Awards in 2010 Kinki Local Commendation for Invention
Summary of Consolidated Financial Results for the Six months Ended September 30, 2010
Announcement Regarding Revision of Business Forecasts
Sysmex Receives Fiscal 2010 Intellectual Property Achievement Award from Ministry of Economy, Trade and Industry Patent Office
Sysmex aims to expand its market share by the World's First Fully Automated Integrated Urine Analyzer jointly developed with ARKRAY
Expansion of Sysmex's Reagent Production Factory in Jinanto Meet Growing Demand in China－Production Structure Capable of Manufacturing Around Five Times the Current Volume－
Summary of Consolidated Financial Results for the Three months Ended June 30, 2010
Sysmex announces business collaboration with Malvern Instruments
Announcement of Organizational Changes
Aiming to the Leading Company in Asia in In-Vitro Diagnostics Sysmex Expanding Portfolio of Clinical Chemistry Products Targeting China and Other Countries in Asia
Sysmex Receives "Invention Award" in 2010 National Commendation for Invention for Reagent for Analyzing Formed Elements in Urine- World First Practical Application of Flow Cytometry to Automated Quantitative Analysis of Formed Elements in Urine-
Sysmex Launches Joint Business with IDEXX, Leader in Pet Diagnostics- Will expand the Global Animal Hospital Market with Automated Hematology Analyzers Supplied by Sysmex -
Consolidated Financial Results for the Year Ended March 31, 2010
Announcement Regarding Change from Business Forecasts and Year-end Dividend for the Year Ended March 2010
Sysmex Group Establishes Long-Term Environmental Objectives- Aiming to Remain a Company That Instills Confidence in All People -
Sysmex Announces Establishment of a Sales and Support Subsidiary: Sysmex Vietnam
Sysmex Starts Joint Research with National Cancer Center Hospital to Verify Clinical Usefulness of Technology for Detecting Circulating Tumor Cells
Announcement of Personnel Changes
Summary of Consolidated Financial Results for the Nine months Ended December 31, 2009
Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business
